Skip to content

DBVT

DBV Technologies SA

NASDAQ · Healthcare · Biotechnology · FR

$9.59
−6.85%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
20.45x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.76x
Price / sales
—
Price / cash flow
-3.02x

Enterprise value

Enterprise value
$448.5M
EV / sales
—
EV / EBITDA
-2.66x
EV / EBIT
-2.48x
Market cap
$602.4M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026